Business, Free News Articles, Funding and Investment

AI Radiology and Emerging Medical Technology Venture Capital Investment Group Now Open to Outside Participation

LOS ANGELES, Calif. -- Seventeen-year-old ProNova Partners has been contracted to facilitate the expansion of an Artificial Intelligence Radiology Imaging and emerging Medical Technology Venture Capital Investment Group.

"This venture capital investment partnership was founded in 2018," announced Rick Carlson, CEO of ProNova Partners. "On behalf of their members, they find and invest in game changing, cutting edge, emerging companies specializing in Artificial Intelligence Radiology Imaging and other Medical Technologies."

"The group is owned and operated by three managing partners with broad ranging domain expertise," continued Carlson. "We are very pleased to work with such a qualified group. They are finding and investing at the early stages in firms at the razor's edge of Artificial Intelligence in medical technology." Carlson's company has assisted the expansion or sale of some 400 companies in a wide variety of market segments.

"The investment group has already seen high quality, sector specific deal flow, and boasts of a robust current portfolio of investments in leading edge technologies," concluded Carlson.

"The investment firm's distinguished Managing Partners' combined credentials span venture capital investment expertise. This includes domain expertise in radiology covering a broad range of aspects of radiology and MRI imaging, entrepreneurship, artificial intelligence, and other emerging medical technologies. Their combined knowledge and experience establish them as ideally suited to spearhead the formation of a selected group of physician and non-physician investors plus providing groundbreaking leadership in early stage company investments in the AI/Imaging/Radiology sector."

For detailed information go to:

Related link:

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Awards and Honors, Business, Free News Articles, Funding and Investment

Nancy Pfund, Pioneering Leader in Impact Investing, Named FWSF Financial Woman of the Year 2022

SAN FRANCISCO, Calif. -- Financial Women of San Francisco (FWSF) today named Nancy Pfund, the Founder and Managing Partner of DBL Partners, as the FWSF 2022 Financial Woman of the Year. DBL Partners is one of the first venture capital firms to bring impact investing into the mainstream. Nancy and her colleagues launched DBL out of JP Morgan in 2008 after seeing increased momentum in the move to social and environmental impact. At DBL (standing for "Double Bottom Line"), Nancy and her team built a firm whose raison d'être is to foster investment with impact. The firm strives to optimize both financial return (First Bottom Line) and positive social impact, including social, environmental and economic benefits (Second Bottom Line) in the regions and sectors in which it invests. Nancy was an early investor in Tesla, SpaceX, SolarCity, and Pandora, among many others.

In addition to her innovation and leadership in building a clean energy future for the planet and putting social impact on the boardroom agenda, Nancy has consistently been an advocate for advancing the participation and leadership of women. Nancy firmly believes that the future will be brighter with a more diverse and representative workforce building it. FWSF shares Nancy's commitment to making an impact, increasing diversity, and advancing women-these are a few of the many reasons why Nancy is being honored by FWSF in 2022.

"Building my finance career in San Francisco over the years," says Nancy, "I have always been struck by the abundance of professional women who lead not only in their own fields, but in proactively helping other women advance in theirs. The Financial Women of San Francisco organization has played a key role in highlighting the importance and accomplishments of Bay Area women in finance, and I am honored to join the ranks of outstanding women who have won this award before me."

Melissa Maquilan Radic, the 2022 President of FWSF and Managing Director of Investor Relations & Capital Markets at IMPACT Community Capital, LLC is particularly excited about this year's honoree. "Nancy Pfund was a leader in the impact investing space long before this type of investing gained the widespread recognition it has today. She is a champion of social and environmental change, both personally and professionally, and is an inspiring role model for women who want to lead in the investment management or impact space. We are so proud to grant Nancy our highest honor and look forward to sharing her insights with the FWSF community."

"When I first started my impact investing journey, it was a lonely place to be," Nancy explained, "Undaunted, and determined to bring the worlds of finance, investment and social and environmental progress together, I relied on the support of early adopters willing to bet on me and on this new vision. Many of these early adopters were women, and women continue to lead in impact today. FWSF embodies the spirit of impact-and its benefits-by steadfastly lifting women up and passing the baton to younger women through its scholarship program that creates the next generation of financial women leaders."

The Financial Woman of the Year award was established in 1996 to celebrate the organization's 40th anniversary. Past FWSF Presidents Leslie Miller and Shelly Porges created the Financial Woman of the Year event with the triple purposes of raising funds for FWSF's scholarship program, increasing awareness of FWSF, and celebrating the careers of senior leaders in finance. Since then, it has provided a platform for high-achieving honorees to share their professional experience with others and to inspire other women in their own careers and ambitions. Nancy joins a distinguished list of former honorees including Jenny Johnson, CEO of Franklin Templeton, Terri Kallsen, Chief Operating Officer at Wealth Enhancement Group, Heidi Roizen, Partner at Threshold Ventures; Robin Washington, former chief financial officer (CFO) of Gilead; Debbie Messemer, former managing partner of KPMG's Bay Area Market; Carrie Dolan, CFO of Kraken Digital Asset Exchange; Sarah Friar, CEO of Next Door and former CFO of Square; and Pat Yarrington, former CFO of Chevron.

About Nancy Pfund

Nancy Pfund is the Founder and Managing Partner of DBL Partners and one of the world's pioneers in impact investing. Through Nancy's passion and leadership, DBL has revealed the power of venture capital to promote social change and environmental improvement. Nancy writes and speaks frequently on the field of impact investing, and she sponsors or sits on the boards of several companies, including; Farmers Business Network, The Muse, Zola Electric, Bellwether Coffee, Spatial, and, prior to their public offerings, Tesla, SolarCity and Pandora. Prior to founding DBL, Nancy was a Managing Director in Venture Capital at JPMorgan, having started her investment career at Hambrecht & Quist in 1984. Previously, Nancy worked at Intel Corporation, The State of California, Stanford University, and the Sierra Club. Nancy received her BA and MA in Anthropology from Stanford University and her MBA from the Yale School of Management.

In September 2020, Nancy was named to the Forbes Impact 50 List of the most notable impact investors. She is also a recipient of the Commonwealth Club 2018 Distinguished Citizen Award and the Earth Day Network 2018 Climate Visionary Award. She was featured as #17 in the 2014 Fortune Inaugural World's Top 25 Eco-Innovators and appeared in Fast Company's 2016 List of Most Creative People in Business.

To learn more about Nancy Pfund's incredible leadership and career, please visit:

About DBL Partners

DBL Partners was formed with a "Double Bottom Line" investment strategy to invest in companies that can deliver top-tier venture capital returns (First Bottom Line), while working with companies to enable social, environmental, and economic improvement in the regions in which they operate (Second Bottom Line).

DBL Partners uses venture capital to accelerate innovation in a way that positively affects an organization's social impact, as well as its financial success. DBL strongly believes that these two drivers-positive social change and healthy financial performance-are inherently connected. DBL invests and helps nurture outstanding entrepreneurs and companies in Cleantech, Information Technology, Sustainable Products and Services and Healthcare.

For more information about DBL Partners, please visit:

About Financial Women of San Francisco

The Financial Women of San Francisco seeks to advance the success of women in finance and financial services and to be a source of insight and inspiration to financial women executives and managers throughout the Bay Area. In addition to the FWSF's professional organization focused on advancing women, since 1985, the FWSF Scholarship Fund (a 501(c)(3) organization) has awarded more than $2.7 million in scholarship grants to more than 325 Bay Area women. Beyond financial support, FWSF scholarship recipients are mentored by FWSF members, become members of the organization, and attend career development and networking events.

For more information, please visit or follow Financial Women of San Francisco on LinkedIn, Facebook and Twitter.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Funding and Investment

Memphis-based Venture Capital Firm Innova Announces Sale of Portfolio Company Arkis Biosciences to Integra LifeSciences

MEMPHIS, Tenn. -- Innova Memphis, a Memphis-based early stage venture capital firm, is pleased to announce the acquisition of its portfolio company Arkis Biosciences. Knoxville-based Arkis, a neuro-surgical medical device company, has been acquired by Integra LifeSciences Holding Corporation, a leading medical technology company.

"The acquisition of Arkis Biosciences strengthens Integra's offerings in neurocritical care and Integra's position as the world leader in advanced catheter technology," according to a press release issued on July 29 by Integra; furthermore Dan Reuvers, president of Codman Specialty Surgical says: "Today's acquisition expands our leading portfolio to better treat patients and underscores our commitment to addressing unmet needs in patient care."

Innova was an early investor in Arkis and led the company's Series A round in 2016.

Ken Woody, Innova President and Arkis Board Chair says: "We were very impressed with the team, and technology from day one. I worked closely with Chad Seaver and the management team, and saw their daily commitment to product quality and compassion for the patients. This was a great outcome for Arkis, and we could not have picked a better company to acquire this lifesaving technology than Integra. I'm very proud of the Arkis team and thrilled with the outcome for our co-investors."

Jan Bouten, Partner at Innova further states, "This is a great win for Tennessee. Arkis was founded by a physician from UT Medical Center and an engineer with a PhD from UT. They got started in the UT Research Foundation Business Incubator. This outcome is a great demonstration of Innova's thesis: 1) invest local, 2) invest early, 3) invest in great teams, and 4) invest in promising technologies that fill a real customer need. From there, we work very closely with the Founders as they grow their business and we bring other investors along with us."

Innova led a strong syndicate of investors who believed in the Arkis team and mission, including Angel Capital Group, Lighthouse Fund, and several other Angel investors from Tennessee and across the U.S. We're grateful for the support these co-investors gave Arkis as they grew and commercialized their product line.

"Many of our investors have a background in healthcare and are passionate impact investors. Innova was an ideal partner for Arkis due to their extensive experience in MedTech and their relationships in the industry. I think it is important for investors of a Medical Device company to appreciate the regulatory hurdles, sales cycles, and other challenges often faced in the industry. I'm grateful for our investors' passion, dedication, and especially for their support and confidence in the team," said Chad Seaver, founder and CEO of Arkis Biosciences.

Financial terms were not disclosed.

About Innova Memphis:

Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in Life Sciences, Technology and AgTech fields. Innova links capital with great ideas to create groundbreaking products and services. With more than $35M deployed in over 100 companies, Innova is one of the most experienced investors in the Mid South and Southeast. The firm was started in Memphis in 2007 by the Bioworks Foundation.

For more information visit

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.